- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
N1VS34
SAO
Week ended 31 Jul 2026
Weekly Investor Report
Novartis AG · Healthcare · Drug Manufacturers - General
Latest close
79.68 BRL
1.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is 2.1% above the Trend Line and sits at 76.0% of its 52-week range. The latest completed week returned 1.3%, after a -3.9% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
52
out of 100
Latest Close
79.68 BRL
31 Jul 2026
1W Return
1.3%
latest completed week
4W Return
-3.9%
short-term follow-through
12W Return
11.9%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- 3 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.3%
Latest completed week; four-week move -3.9%.
Indicator stack
43/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 2.1% above the Trend Line and sits at 76.0% of its 52-week range. The latest completed week returned 1.3%, after a -3.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6112-week average 0.53
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.9% over four weeks, 11.9% over 12 weeks, and 27.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.33Latest activity-pressure read.
Pressure change306.2%Four-week change in activity pressure.
Leadership0.44Latest relative-leadership reading.
RS change-92.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 13 relevant articles.
2 positive · 10 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.9%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher14 of 2612 weeks finished lower.
Best week+6.3%Week of 13 Feb.
Worst week-5.0%Week of 10 Jul.
Latest week+1.3%Week of 31 Jul.
Shape of recent returns
Strong gains3
Modest gains11
Flat weeks0
Modest losses11
Sharp losses1
Recent vol3.0%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank53 / 81
Group average-2.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD65.4%positive activity pressure
RS37.0%positive relative leadership
Four-week leaders
IndustryBR Drug Manufacturers - General
4-week rank7 / 13
Group average-3.8%
Trend breadth38.5%
Trend38.5%active weekly trend signals
MD69.2%positive activity pressure
RS53.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis39/100Latest 12-week confirmation: trend 2/12, activity pressure 5/12, relative leadership 8/12.
Activity pressure 0.61; 3 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 13 relevant articles.
Novartis AG (TSX:NVS) Stock Price, Trades & News Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 79.68 BRL | 1.3% | 78.03 BRL | 55.24 BRL | 0.33 | 0.44 | 618 | Off |
| 24 Jul 2026 | 78.64 BRL | 0.2% | 77.83 BRL | 54.28 BRL | 0.45 | 1.28 | 7.3K | Off |
| 17 Jul 2026 | 78.50 BRL | -0.3% | 77.73 BRL | 53.33 BRL | 0.46 | 1.16 | 16 | Off |
| 10 Jul 2026 | 78.72 BRL | -5.0% | 77.59 BRL | 52.38 BRL | 0.25 | -0.98 | 48 | Off |
| 3 Jul 2026 | 82.90 BRL | 2.6% | 77.31 BRL | 51.45 BRL | 0.08 | 6.17 | 1.1K | On |
| 26 Jun 2026 | 80.80 BRL | 5.9% | 76.88 BRL | 50.50 BRL | -0.38 | 4.11 | 1.0K | On |
| 19 Jun 2026 | 76.31 BRL | -1.8% | 76.48 BRL | 49.55 BRL | -0.76 | 1.05 | 1 | Off |
| 12 Jun 2026 | 77.70 BRL | 1.1% | 76.14 BRL | 48.62 BRL | -0.78 | 1.35 | 56 | Off |
| 5 Jun 2026 | 76.88 BRL | 1.1% | 75.79 BRL | 47.68 BRL | -0.87 | 1.47 | 32 | Off |
| 29 May 2026 | 76.08 BRL | -1.0% | 75.45 BRL | 46.74 BRL | -0.94 | -2.43 | 438 | Off |
| 22 May 2026 | 76.85 BRL | 2.7% | 75.09 BRL | 45.82 BRL | -0.97 | -2.96 | 324 | Off |
| 15 May 2026 | 74.80 BRL | 5.1% | 74.82 BRL | 44.89 BRL | -1.05 | -6.19 | 44 | Off |
| 8 May 2026 | 71.19 BRL | -3.6% | 74.63 BRL | 43.95 BRL | -1.07 | -14.08 | 155 | Off |
| 1 May 2026 | 73.85 BRL | 1.4% | 74.61 BRL | 43.04 BRL | -0.92 | -12.61 | 1.2K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.